Back to Search
MICHAEL O'BRIEN, DO
DO
Internal Medicine Physician
NPI: 1043343056IndividualAccepts Medicare
Education
OTHER
Class of 2012
Research & Publications (20)
Time and chemotherapy treatment trends in the treatment of elderly patients (age>or=70 years) with non-small cell lung cancer.
PMID 18093813·Clin Oncol (R Coll Radiol)·2008
4-observational
Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer.
PMID 18043124·Anticancer Drugs·2008
6-review
Recent advances with topotecan in the treatment of lung cancer.
PMID 17962613·Oncologist·2007
6-review
Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients.
PMID 17160081·Br J Cancer·2006
8-other
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.
PMID 17135646·J Clin Oncol·2006
3-trial
A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial.
PMID 16317014·Ann Oncol·2006
3-trial
SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results.
PMID 15151947·Ann Oncol·2004
3-trial
Debridement: ethical, legal and practical considerations.
PMID 12682613·Br J Community Nurs·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 273 County Rd
New London, NH 03257 - Phone
- (540) 553-1632
Quick Facts
- NPI
- 1043343056
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile